BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 19456402)

  • 1. Effects of PACAP and preconditioning against ischemia/reperfusion-induced cardiomyocyte apoptosis in vitro.
    Roth E; Wéber G; Kiss P; Horváth G; Tóth G; Gasz B; Ferencz A; Gallyas F; Reglodi D; Rácz B
    Ann N Y Acad Sci; 2009 Apr; 1163():512-6. PubMed ID: 19456402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKA-Bad-14-3-3 and Akt-Bad-14-3-3 signaling pathways are involved in the protective effects of PACAP against ischemia/reperfusion-induced cardiomyocyte apoptosis.
    Rácz B; Gasz B; Gallyas F; Kiss P; Tamás A; Szántó Z; Lubics A; Lengvári I; Tóth G; Hegyi O; Roth E; Reglodi D
    Regul Pept; 2008 Jan; 145(1-3):105-15. PubMed ID: 17981349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis.
    Gasz B; Rácz B; Roth E; Borsiczky B; Ferencz A; Tamás A; Cserepes B; Lubics A; Gallyas F; Tóth G; Lengvári I; Reglodi D
    Peptides; 2006 Jan; 27(1):87-94. PubMed ID: 16095757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PACAP inhibits oxidative stress-induced activation of MAP kinase-dependent apoptotic pathway in cultured cardiomyocytes.
    Gasz B; Rácz B; Röth E; Borsiczky B; Tamás A; Boronkai A; Gallyas F; Tóth G; Reglodi D
    Ann N Y Acad Sci; 2006 Jul; 1070():293-7. PubMed ID: 16891268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of beta2-adrenergic agonist clenbuterol on ischemia/reperfusion injury in isolated rat hearts and cardiomyocyte apoptosis induced by hydrogen peroxide.
    Liu P; Xiang JZ; Zhao L; Yang L; Hu BR; Fu Q
    Acta Pharmacol Sin; 2008 Jun; 29(6):661-9. PubMed ID: 18501112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of pituitary adenylate cyclase activating polypeptide in endothelial cells against oxidative stress-induced apoptosis.
    Rácz B; Gasz B; Borsiczky B; Gallyas F; Tamás A; Józsa R; Lubics A; Kiss P; Roth E; Ferencz A; Tóth G; Hegyi O; Wittmann I; Lengvári I; Somogyvári-Vigh A; Reglodi D
    Gen Comp Endocrinol; 2007; 153(1-3):115-23. PubMed ID: 17270184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PACAP ameliorates oxidative stress in the chicken inner ear: an in vitro study.
    Racz B; Horvath G; Reglodi D; Gasz B; Kiss P; Gallyas F; Sumegi B; Toth G; Nemeth A; Lubics A; Tamas A
    Regul Pept; 2010 Feb; 160(1-3):91-8. PubMed ID: 19969027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) show increased susceptibility to in vivo renal ischemia/reperfusion injury.
    Szakaly P; Laszlo E; Kovacs K; Racz B; Horvath G; Ferencz A; Lubics A; Kiss P; Tamas A; Brubel R; Opper B; Baba A; Hashimoto H; Farkas J; Matkovits A; Magyarlaki T; Helyes Z; Reglodi D
    Neuropeptides; 2011 Apr; 45(2):113-21. PubMed ID: 21211837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuroprotective effects of PACAP in monosodium glutamate-induced retinal lesion involve inhibition of proapoptotic signaling pathways.
    Rácz B; Gallyas F; Kiss P; Tóth G; Hegyi O; Gasz B; Borsiczky B; Ferencz A; Roth E; Tamás A; Lengvári I; Lubics A; Reglodi D
    Regul Pept; 2006 Nov; 137(1-2):20-6. PubMed ID: 16945433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleiotropic functions of PACAP in the CNS: neuroprotection and neurodevelopment.
    Shioda S; Ohtaki H; Nakamachi T; Dohi K; Watanabe J; Nakajo S; Arata S; Kitamura S; Okuda H; Takenoya F; Kitamura Y
    Ann N Y Acad Sci; 2006 Jul; 1070():550-60. PubMed ID: 16888224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective action of urocortin in early pre- and postconditioning.
    Cserepes B; Jancsó G; Gasz B; Rácz B; Ferenc A; Benkó L; Borsiczky B; Kürthy M; Ferencz S; Lantos J; Gál J; Arató E; Miseta A; Wéber G; Róth E
    Ann N Y Acad Sci; 2007 Jan; 1095():228-39. PubMed ID: 17404036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in pituitary adenylate cyclase-activating polypeptide following renal ischemia-reperfusion in rats.
    Szakaly P; Horvath G; Kiss P; Laszlo E; Farkas J; Furjes G; Nemeth J; Reglodi D
    Transplant Proc; 2010; 42(6):2283-6. PubMed ID: 20692463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary adenylate cyclase-activating polypeptide inhibits caspase-3 activity but does not protect cerebellar granule neurons against beta-amyloid (25-35)-induced apoptosis.
    Vaudry D; Cottet-Rousselle C; Basille M; Falluel-Morel A; Fournier A; Vaudry H; Gonzalez BJ
    Regul Pept; 2004 Dec; 123(1-3):43-9. PubMed ID: 15518892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of PACAP on mitochondrial apoptotic pathways and cytokine expression in rats subjected to renal ischemia/reperfusion.
    Horvath G; Racz B; Reglodi D; Kovacs K; Kiss P; Gallyas F; Bognar Z; Szabo A; Magyarlaki T; Laszlo E; Lubics A; Tamas A; Toth G; Szakaly P
    J Mol Neurosci; 2010 Nov; 42(3):411-8. PubMed ID: 20229361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of PACAP against doxorubicin-induced cell death in cardiomyocyte culture.
    Racz B; Reglodi D; Horvath G; Szigeti A; Balatonyi B; Roth E; Weber G; Alotti N; Toth G; Gasz B
    J Mol Neurosci; 2010 Nov; 42(3):419-27. PubMed ID: 20405239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mice deficient in pituitary adenylate cyclase activating polypeptide display increased sensitivity to renal oxidative stress in vitro.
    Horvath G; Mark L; Brubel R; Szakaly P; Racz B; Kiss P; Tamas A; Helyes Z; Lubics A; Hashimoto H; Baba A; Shintani N; Furjes G; Nemeth J; Reglodi D
    Neurosci Lett; 2010 Jan; 469(1):70-4. PubMed ID: 19932736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary adenylate cyclase-activating polypeptide is up-regulated in cortical pyramidal cells after focal ischemia and protects neurons from mild hypoxic/ischemic damage.
    Stumm R; Kolodziej A; Prinz V; Endres M; Wu DF; Höllt V
    J Neurochem; 2007 Nov; 103(4):1666-81. PubMed ID: 17868305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ischemic preconditioning on pancreatic regeneration and pancreatic expression of vascular endothelial growth factor and platelet-derived growth factor-A in ischemia/reperfusion-induced pancreatitis.
    Dembiński A; Warzecha Z; Ceranowicz P; Dembiński M; Cieszkowski J; Pawlik WW; Tomaszewska R; Konturek SJ; Konturek PC
    J Physiol Pharmacol; 2006 Mar; 57(1):39-58. PubMed ID: 16601314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of PACAP on in vitro and in vivo neuronal cell death, platelet aggregation, and production of reactive oxygen radicals.
    Reglodi D; Fábián Z; Tamás A; Lubics A; Szeberényi J; Alexy T; Tóth K; Márton Z; Borsiczky B; Rõth E; Szalontay L; Lengvári I
    Regul Pept; 2004 Dec; 123(1-3):51-9. PubMed ID: 15518893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemic preconditioning of the hindlimb or kidney does not attenuate the severity of acute ischemia/reperfusion-induced pancreatitis in rats.
    Warzecha Z; Dembiński A; Ceranowicz P; Cieszkowski J; Konturek SJ; Dembiński M; Kuśnierz-Cabala B; Tomaszewska R; Pawlik WW
    J Physiol Pharmacol; 2008 Jun; 59(2):337-52. PubMed ID: 18622049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.